For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

Chronic hepatitis B (CHB) is a major health problem affecting large numbers of people worldwide. The major goals of therapy for CHB patients are the prevention of progression to irreversible liver damage. Current therapies are sub-optimal, as they can result in adverse reactions and resistance on the part of the hepatitis B virus. Annikki de Niet explores new treatment strategies for CHB patients.

Event details of New treatment strategies for chronic hepatitis B
Date 2 February 2016
Time 14:00 -15:00
Location Agnietenkapel
Room Location

A. de Niet: New Treatment Strategies for Chronic Hepatitis B. Viral, Genetic and Immunological Factors Predicting Treatment Outcome.

Supervisors

Prof. H.L. Zaaijer

Prof. U.H.W. Beuers

Co-supervisors

Dr E.M.M. van Leeuwen

Dr H.W. Reesink

Agnietenkapel

Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.